NASDAQ:YTEN Yield10 Bioscience - YTEN Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Yield10 Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $2.76 +0.01 (+0.36%) (As of 03/31/2023 12:00 AM ET) Add Compare Share Share Today's Range$2.60▼$2.8050-Day Range$2.31▼$4.1052-Week Range$1.63▼$6.12Volume10,446 shsAverage Volume78,035 shsMarket Capitalization$14.00 millionP/E RatioN/ADividend YieldN/APrice Target$12.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Yield10 Bioscience MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside334.8% Upside$12.00 Price TargetShort InterestHealthy2.69% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.64) to ($0.80) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.64 out of 5 starsConsumer Staples Sector116th out of 138 stocksAgricultural Production - Crops Industry9th out of 11 stocks 3.5 Analyst's Opinion Consensus RatingYield10 Bioscience has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $12.00, Yield10 Bioscience has a forecasted upside of 334.8% from its current price of $2.76.Amount of Analyst CoverageYield10 Bioscience has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.69% of the float of Yield10 Bioscience has been sold short.Short Interest Ratio / Days to CoverYield10 Bioscience has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Yield10 Bioscience has recently increased by 10.16%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldYield10 Bioscience does not currently pay a dividend.Dividend GrowthYield10 Bioscience does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for YTEN. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Yield10 Bioscience this week, compared to 0 articles on an average week.MarketBeat FollowsOnly 1 people have added Yield10 Bioscience to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Yield10 Bioscience insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 5.30% of the stock of Yield10 Bioscience is held by insiders.Percentage Held by InstitutionsOnly 7.69% of the stock of Yield10 Bioscience is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Yield10 Bioscience are expected to grow in the coming year, from ($1.64) to ($0.80) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Yield10 Bioscience is -1.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Yield10 Bioscience is -1.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioYield10 Bioscience has a P/B Ratio of 3.10. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Yield10 Bioscience (NASDAQ:YTEN) StockYield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company was founded by Anthony J. Sinskey, Simon F. Williams, and Oliver P. Peoples in 1992 and is headquartered in Woburn, MA.Read More Receive YTEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Yield10 Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address YTEN Stock News HeadlinesMarch 28, 2023 | americanbankingnews.comYield10 Bioscience (NASDAQ:YTEN) & Limoneira (NASDAQ:LMNR) Financial ComparisonMarch 17, 2023 | finance.yahoo.comYield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2022 Earnings Call TranscriptApril 2, 2023 | Investorplace Media (Ad)5 Hypergrowth Stocks to Buy NowLuke Lango has found 14 stocks that have gone up over 1,000%. Now he’s named his top stocks for 2023. Just click to claim your copy. March 16, 2023 | markets.businessinsider.comAnalysts Offer Insights on Materials Companies: Franco-Nevada (FNV) and Yield10 Bioscience (YTEN)March 15, 2023 | finanznachrichten.deYield10 Bioscience, Inc.: Yield10 Bioscience Announces Fourth Quarter and Full Year 2022 Financial ResultsMarch 15, 2023 | msn.comYield10 Bioscience's Return On Capital Employed InsightsMarch 15, 2023 | markets.businessinsider.comLake Street Reaffirms Their Buy Rating on Yield10 Bioscience (YTEN)March 15, 2023 | finance.yahoo.comQ4 2022 Yield10 Bioscience Inc Earnings CallApril 2, 2023 | Vantage Point (Ad)Did You See These Trend Reversals?Get ready for a potentially shocking and unprecedented announcement from the Fed meeting on May 3rd. This could cause many retail and industry traders to resort to drastic measures. One swift stroke could make popular assets plummet, BUT… there’s a straightforward solution to act now to protect your family and wealth. March 14, 2023 | finance.yahoo.comYield10 Bioscience Announces Fourth Quarter and Full Year 2022 Financial ResultsMarch 13, 2023 | msn.comA Preview Of Yield10 Bioscience's EarningsMarch 8, 2023 | finance.yahoo.comYield10 Bioscience to Announce Fourth Quarter and Full Year 2022 Financial Results and Host a Conference Call on Tuesday, March 14, 2023March 2, 2023 | msn.comWhy Yield10 Bioscience Stock Is Taking Off ThursdayFebruary 21, 2023 | finance.yahoo.comYield10 Bioscience Announces Key Advancements in the Development of Herbicide Tolerant Camelina Supporting Large Acreage Production of Low-carbon Intensity Feedstock Oil for the Biofuel MarketFebruary 16, 2023 | finance.yahoo.comYield10 Bioscience to Present at the Third Annual Winter Wonderland - Best Ideas 2023 Virtual Conference on February 21, 2023January 13, 2023 | marketwatch.comYield10 Bioscience Shares Decline 8.3%, Paring Back Gains on Potential Biofuel PartnershipJanuary 13, 2023 | benzinga.comShort Volatility Alert: Yield10 BioscienceJanuary 12, 2023 | markets.businessinsider.comLake Street Keeps Their Buy Rating on Yield10 Bioscience (YTEN)January 11, 2023 | marketwatch.comYield10 Bioscience Stock Up 53% on Potential Biofuel Partnership with MitsubishiJanuary 11, 2023 | finance.yahoo.comYield10 Bioscience and Mitsubishi Corporation Sign MOU to Evaluate the Establishment of a Partnership to Supply, Offtake and Market Camelina as a Feedstock Oil for BiofuelNovember 21, 2022 | finance.yahoo.comYield10 Bioscience to Present at the CG AgriFood Tech Innovation Virtual ForumNovember 21, 2022 | finance.yahoo.comYield10 Bioscience to Present at the CG AgriFood Tech Innovation Virtual ForumNovember 17, 2022 | finance.yahoo.comYield10 Bioscience Third Quarter 2022 Earnings: Misses ExpectationsNovember 15, 2022 | finance.yahoo.comYield10 Bioscience Announces Third Quarter 2022 Financial ResultsNovember 15, 2022 | seekingalpha.comYield10 Bioscience, Inc. (YTEN) Q3 2022 Earnings Call TranscriptNovember 10, 2022 | finance.yahoo.comYield10 Bioscience Begins Winter 2022/2023 Field Test and Seed Production ProgramNovember 7, 2022 | finance.yahoo.comYield10 Bioscience to Announce Third Quarter 2022 Financial Results and Host a Conference Call on Monday, November 14, 2022See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive YTEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Yield10 Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address YTEN Company Calendar Last Earnings11/09/2021Today4/02/2023Next Earnings (Estimated)5/10/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Agricultural production - crops Sub-IndustryN/A SectorConsumer Staples Current SymbolNASDAQ:YTEN CUSIPN/A CIK1121702 Webwww.yield10bio.com Phone(617) 583-1700Fax617-583-1768Employees29Year Founded1992Price Target and Rating Average Stock Price Forecast$12.00 High Stock Price Forecast$12.00 Low Stock Price Forecast$12.00 Forecasted Upside/Downside+334.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($2.76) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-13,570,000.00 Net Margins-3,014.67% Pretax Margin-2,980.00% Return on Equity-154.59% Return on Assets-106.96% Debt Debt-to-Equity RatioN/A Current Ratio3.12 Quick Ratio3.12 Sales & Book Value Annual Sales$450,000.00 Price / Sales31.12 Cash FlowN/A Price / Cash FlowN/A Book Value$0.89 per share Price / Book3.10Miscellaneous Outstanding Shares5,074,000Free Float4,805,000Market Cap$14.00 million OptionableNot Optionable Beta1.75 Social Links Key ExecutivesOliver P. PeoplesPresident, Chief Executive Officer & DirectorCharles B. HaaserChief Accounting Officer, Treasurer & VP-FinanceKristi D. SnellChief Science Officer & Vice President-ResearchNicholas RenegarDirector-Business Analytics & OperationsLynne H. BrumSecretary, VP-Planning & CommunicationsKey CompetitorsOrigin AgritechNASDAQ:SEEDStryve FoodsNASDAQ:SNAXDAVIDsTEANASDAQ:DTEANoceraNASDAQ:NCRAAgriFORCE Growing SystemsNASDAQ:AGRIView All CompetitorsInsiders & InstitutionsCannell & Co.Bought 97,600 shares on 2/3/2023Ownership: 5.219%Anthony J SinskeyBought 2,000 shares on 8/17/2022Total: $5,600.00 ($2.80/share)Anthony J SinskeyBought 2,000 shares on 8/15/2022Total: $5,540.00 ($2.77/share)View All Insider TransactionsView All Institutional Transactions YTEN Stock - Frequently Asked Questions Should I buy or sell Yield10 Bioscience stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Yield10 Bioscience in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" YTEN shares. View YTEN analyst ratings or view top-rated stocks. What is Yield10 Bioscience's stock price forecast for 2023? 2 analysts have issued 1-year target prices for Yield10 Bioscience's shares. Their YTEN share price forecasts range from $12.00 to $12.00. On average, they anticipate the company's share price to reach $12.00 in the next year. This suggests a possible upside of 334.8% from the stock's current price. View analysts price targets for YTEN or view top-rated stocks among Wall Street analysts. How have YTEN shares performed in 2023? Yield10 Bioscience's stock was trading at $1.6695 at the beginning of the year. Since then, YTEN shares have increased by 65.3% and is now trading at $2.76. View the best growth stocks for 2023 here. When is Yield10 Bioscience's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 10th 2023. View our YTEN earnings forecast. How were Yield10 Bioscience's earnings last quarter? Yield10 Bioscience, Inc. (NASDAQ:YTEN) posted its quarterly earnings results on Tuesday, November, 9th. The specialty chemicals company reported ($0.49) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.65) by $0.16. The specialty chemicals company had revenue of $0.09 million for the quarter, compared to analyst estimates of $0.22 million. Yield10 Bioscience had a negative net margin of 3,014.67% and a negative trailing twelve-month return on equity of 154.59%. During the same quarter in the previous year, the firm posted ($0.87) earnings per share. When did Yield10 Bioscience's stock split? Shares of Yield10 Bioscience reverse split before market open on Thursday, January 16th 2020. The 1-40 reverse split was announced on Wednesday, January 15th 2020. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, January 15th 2020. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. What other stocks do shareholders of Yield10 Bioscience own? Based on aggregate information from My MarketBeat watchlists, some companies that other Yield10 Bioscience investors own include KushCo (KSHB), OPKO Health (OPK), T2 Biosystems (TTOO), FuelCell Energy (FCEL), TherapeuticsMD (TXMD), Viking Therapeutics (VKTX), Rigel Pharmaceuticals (RIGL), Advanced Micro Devices (AMD). What is Yield10 Bioscience's stock symbol? Yield10 Bioscience trades on the NASDAQ under the ticker symbol "YTEN." How do I buy shares of Yield10 Bioscience? Shares of YTEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Yield10 Bioscience's stock price today? One share of YTEN stock can currently be purchased for approximately $2.76. How much money does Yield10 Bioscience make? Yield10 Bioscience (NASDAQ:YTEN) has a market capitalization of $14.00 million and generates $450,000.00 in revenue each year. The specialty chemicals company earns $-13,570,000.00 in net income (profit) each year or ($2.76) on an earnings per share basis. How can I contact Yield10 Bioscience? Yield10 Bioscience's mailing address is 19 PRESIDENTIAL WAY, WOBURN MA, 01801. The official website for the company is www.yield10bio.com. The specialty chemicals company can be reached via phone at (617) 583-1700, via email at brets@coreir.com, or via fax at 617-583-1768. This page (NASDAQ:YTEN) was last updated on 4/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.